Stoke Corp - STOK Quarterly EPS earnings growth

Brandmark of Stoke (STOK)

Stoke Therapeutics (STOK) develops methods for restoring gene functions without DNA editing, enabling the treatment of incurable pathologies. The quarterly EPS trend reflects the current stage of development, with the metric currently standing at -64.10. However, high costs and strict oversight create risks that the company mitigates through redundant biomaterial supply chains from Europe and the US.

Stoke Therapeutics, Inc. (STOK) - Earnings per share growth in annualized terms for the last twelve months from 07/04/2022 to 11/15/2026

STOK (stoketherapeutics.com): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Stock Quotes Stoke Therapeutics, Inc.|STOK - Analyst Forecast Prices
- issuer market value details:
Market Capitalization Stoke Therapeutics, Inc.|STOK - Value Adjusted for Debt and Cash
- balance sheet net asset value indicators:
Book Value per Share Stoke Therapeutics|STOK - Total Stockholders' Equity|Market Value to Book Value Ratio stoketherapeutics.com|STOK - Aggregate Asset Value
- business debt structure and liquidity details:
Total Debt to Capital Stoke Therapeutics|STOK - Long-Term Debt to Capital|Short-Term Debt to Equity Stoke Therapeutics|STOK - Company Aggregate Indebtedness|Debts to Book Capitalization Stoke|STOK - Long-Term Debt|Company Current Liabilities Stoke Therapeutics|Quick Liquidity Indicator stoketherapeutics.com
- earnings and valuation multiples indicators:
STOK - Profit After Payment of Taxes|Projected Future Earnings Stoke Therapeutics|STOK - Business Payback Period|Forward P/E Multiple stoketherapeutics.com|STOK - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Stoke Therapeutics Inc|STOK - Operating income before deduction of amortization|Earnings per share for the last twelve months Stoke Therapeutics|STOK - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months stoketherapeutics.com|STOK - Net earnings per one share growth for the current year|Net earnings per share growth forecast for next year Stoke Therapeutics
- sales volume and revenue indicators:
STOK - Company Total Revenue|Company Projected Revenue Stoke Therapeutics Inc|STOK - P/S Multiple|Forward P/S Multiple Stoke Therapeutics Inc
General company analysis:stoketherapeutics.com - STOK
Flagship merchandise of Stoke Therapeutics

The metric is calculated as the percentage change in net earnings per share compared to the same period last year. This indicator captures the fundamental trend, signaling a shift in operational efficiency. For Stoke Therapeutics (STOK), this calculation directly reflects the development cost of the STK-001 molecule. FDA clinical phase results and cash burn management drive the volatility of quarterly earnings per share growth. By analyzing this chart, an investor assesses the financial stability of the biotech firm.

Analysis of competing companies

TEM: Quarterly EPS earnings growth|Qiagen Corp - Year-over-year earnings per one share growth for the last 12 months|IONS (Ionis Pharmaceuticals) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RGEN (Repligen)|Quarterly EPS earnings growth RNA|CRSP (CRISPR Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth WGS (GeneDx Holdings Corp.)|RARE: Year-over-year earnings per share growth for the last 12 months|BEAM - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months sarepta.com|TWST: Quarterly EPS earnings growth|TXG - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Intellia|BLFS (BioLife Corp) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months Wave Life Sciences Ltd. (WVE)|Year-over-year earnings per share growth rate for the last twelve months MAZE|sionnatx.com - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PRME|TSHA - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months uniQure Corp|meiragtx.com (MGTX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months RGNX|Year-over-year net earnings per share growth for the last 12 months SLDB|Quarterly EPS earnings growth Ocugen Inc|Year-over-year earnings per share growth for the last twelve months PacBio Corp (PACB)|Year-over-year net earnings per share change for the last twelve months Benitec Corp|Quarterly EPS earnings growth DSGN (Design Therapeutics, Inc.)|Quarterly EPS earnings growth rocketpharma.com RCKT|4DMT - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Lexeo Therapeutics, Inc.|Korro Bio (KRRO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months EDIT|SLN (Silence Therapeutics plc) - Quarterly EPS earnings growth|proqr.com (PRQR) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CDXS (Codexis Bio)|SGMO - Earnings per share growth in annualized terms for the last twelve months|Nautilus Biotechnology, Inc. - Year-over-year net earnings per share growth for the last 12 months|Net earnings per share growth for the trailing year Metagenomi, Inc|Precision BioSciences - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year generationbio.com (GBIO)|Boundless Bio Inc (BOLD) - Year-over-year earnings per share growth for the last twelve months|Exicure Inc. - Year-over-year earnings per one share growth for the last 12 months|IMNN (imunon.com) - Quarterly EPS earnings growth|Phio Pharmaceuticals - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Mustang Bio Corp (MBIO)|Quarterly EPS earnings growth TransCode (RNAZ)|Quarterly EPS earnings growth BNGO (bionanogenomics.com)|APDN (Applied DNA Sciences Inc) - Year-over-year net earnings per share trend for the last twelve months|BLUE - Year-over-year earnings per share growth for the last twelve months|ImmunoPrecise Antibodies Ltd. (IPA) - Year-over-year net earnings per share growth for the last 12 months|OMGA (Omega) - Year-over-year net earnings per share growth for the last 12 months|singulargenomics.com (OMIC) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months RGLS|Syros (SYRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months telesisbio.com (TBIO)|TCON - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth UBX (Unity Biotechnology Inc.)